JP6320040B2 - 抗ｐｒｏｋ１抗体及び抗ｖｅｇｆ抗体併用による大腸癌の治療 - Google Patents

抗ｐｒｏｋ１抗体及び抗ｖｅｇｆ抗体併用による大腸癌の治療 Download PDF

Info

Publication number
JP6320040B2
JP6320040B2 JP2013273140A JP2013273140A JP6320040B2 JP 6320040 B2 JP6320040 B2 JP 6320040B2 JP 2013273140 A JP2013273140 A JP 2013273140A JP 2013273140 A JP2013273140 A JP 2013273140A JP 6320040 B2 JP6320040 B2 JP 6320040B2
Authority
JP
Japan
Prior art keywords
antibody
prok1
vegf
colorectal cancer
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013273140A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015127308A5 (enExample
JP2015127308A (ja
Inventor
明夫 山口
明夫 山口
孝憲 五井
孝憲 五井
俊之 中澤
俊之 中澤
秀崇 呉林
秀崇 呉林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Fukui NUC
Original Assignee
University of Fukui NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Fukui NUC filed Critical University of Fukui NUC
Priority to JP2013273140A priority Critical patent/JP6320040B2/ja
Publication of JP2015127308A publication Critical patent/JP2015127308A/ja
Publication of JP2015127308A5 publication Critical patent/JP2015127308A5/ja
Application granted granted Critical
Publication of JP6320040B2 publication Critical patent/JP6320040B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2013273140A 2013-12-27 2013-12-27 抗ｐｒｏｋ１抗体及び抗ｖｅｇｆ抗体併用による大腸癌の治療 Active JP6320040B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013273140A JP6320040B2 (ja) 2013-12-27 2013-12-27 抗ｐｒｏｋ１抗体及び抗ｖｅｇｆ抗体併用による大腸癌の治療

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013273140A JP6320040B2 (ja) 2013-12-27 2013-12-27 抗ｐｒｏｋ１抗体及び抗ｖｅｇｆ抗体併用による大腸癌の治療

Publications (3)

Publication Number Publication Date
JP2015127308A JP2015127308A (ja) 2015-07-09
JP2015127308A5 JP2015127308A5 (enExample) 2017-02-09
JP6320040B2 true JP6320040B2 (ja) 2018-05-09

Family

ID=53837492

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013273140A Active JP6320040B2 (ja) 2013-12-27 2013-12-27 抗ｐｒｏｋ１抗体及び抗ｖｅｇｆ抗体併用による大腸癌の治療

Country Status (1)

Country Link
JP (1) JP6320040B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230139178A1 (en) * 2020-03-12 2023-05-04 Toray Industries, Inc. Medicament for treatment and/or prevention of cancer
JP2022122736A (ja) * 2021-02-10 2022-08-23 国立大学法人福井大学 抗ｐｒｏｋ１抗体の利用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020172678A1 (en) * 2000-06-23 2002-11-21 Napoleone Ferrara EG-VEGF nucleic acids and polypeptides and methods of use
JP2003292455A (ja) * 2002-02-04 2003-10-15 Takeda Chem Ind Ltd 血管新生阻害剤

Also Published As

Publication number Publication date
JP2015127308A (ja) 2015-07-09

Similar Documents

Publication Publication Date Title
RU2568051C2 (ru) АНТИТЕЛА К ErbB3
JP5302007B2 (ja) インスリン様増殖因子に特異的な結合タンパク質およびその使用
CN1961003B (zh) 人源化抗TGF-β抗体
JP2021531826A (ja) 栄養膜細胞表面抗原２（ｔｒｏｐ２）に対する特異的な抗体
JP5908972B2 (ja) 新規な抗原結合タンパク質
KR102200274B1 (ko) 항-ｍｅｔ 항체 및 조성물
JP2022514693A (ja) Ｍｕｃ１８に特異的な抗体
TW201231066A (en) Pan-HER antibody composition
TW201402610A (zh) 抗－ｅｇｆｒ抗體及其用途
TW201329103A (zh) 抗－ＥｒｂＢ３抗體及其用途
TW200932268A (en) Binding molecules to the human OX40 receptor
KR102608028B1 (ko) 인간 원형질막 소포 관련 단백질 pv-1에 특이적으로 결합하는 단일클론항체 및 이의 제조방법과 용도
JP2022523710A (ja) Ｃｄ４４に特異的な抗体
US10179816B2 (en) Pharmaceutical compositions comprising an antibody which binds the human anti-Müllerian hormone receptor type II
TW200902549A (en) Anti-FGF23 antibody and pharmaceutical composition comprising the same
US12060416B2 (en) Humanized anti-VEGF monoclonal antibody
WO2021115303A1 (zh) 一种抗Claudin18.2单克隆抗体、其制备方法及用途
WO2019076277A1 (zh) 抗pd-1抗体和抗lag-3抗体联合在制备治疗肿瘤的药物中的用途
JP2022514786A (ja) Ｍｕｃ１８に特異的な抗体
WO2023143590A1 (zh) 采用抗il-11抗体的肿瘤组合疗法
EP2766045B1 (en) Treatment of breast cancer with companion diagnostic
TW202043271A (zh) 重組抗人程序性細胞死亡蛋白1抗體及其應用
US20220089757A1 (en) Anti-cd137l antibodies and methods of using same
JP6320040B2 (ja) 抗ｐｒｏｋ１抗体及び抗ｖｅｇｆ抗体併用による大腸癌の治療
JP2015127307A (ja) 抗ｐｒｏｋ１抗体による大腸癌の治療

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161222

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170822

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171023

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20171023

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180313

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180403

R150 Certificate of patent or registration of utility model

Ref document number: 6320040

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250